We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Bayer AG | TG:BAYN | Tradegate | Ordinary Share |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.965 | 3.53% | 28.28 | 28.205 | 28.35 | 28.775 | 27.815 | 27.88 | 525,347 | 22:50:04 |
By Joshua Stein
Shares in Bayer AG rose on Thursday after the German chemical and pharmaceutical giant proposed a $2 billion deal to address future litigation over its controversial glyphosate-based weedkiller Roundup.
At 1106 GMT, shares in Bayer traded 4.8% higher at EUR53.97.
Bayer's proposal, released late Wednesday, would discount the need for further financial provisions associated with the Roundup weedkiller in the U.S., which some claim causes cancer.
Analysts were widely upbeat on the development. Citi said the proposal should boost market sentiment, while UBS said the proposals "seem to address the judge's concerns" raised over Bayer's first proposal in July.
Bayer has been dealing with litigation over Roundup safety since it acquired Monsanto Co., the weedkiller's manufacturer, in 2018.
The company agreed last June to pay up to $9.6 billion to settle existing Roundup cases, while continuing to deny any connection between the product and cancer. That deal didn't prevent more plaintiffs from coming forward in the future.
Write to Joshua Stein at joshua.stein@wsj.com
(END) Dow Jones Newswires
February 04, 2021 06:26 ET (11:26 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year Bayer Chart |
1 Month Bayer Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions